Literature DB >> 11095130

Lateral rectus split in the management of Duane's Retraction Syndrome.

J C Das1, Z Chaudhuri, S Bhomaj, P Sharma.   

Abstract

This case reports Type I Duane's Retraction Syndrome with marked upshoot of the globe in adduction. An 18-year-old patient presented with complaints of not being able to move his left eye outwards since childhood. A 'Y' split of the lateral rectus muscle was performed in the affected eye. There was marked cosmetic and functional improvement in the patient which was stable after 6 months of follow-up. Y splitting of the lateral rectus muscle is a simple technique that can be used effectively in the treatment of marked upshoot or downshoot in Duane's Retraction Syndrome.

Entities:  

Mesh:

Year:  2000        PMID: 11095130

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  5 in total

1.  Reduction of ocular muscle torque by splitting of the rectus muscle II: technique and results.

Authors:  R Hoerantner; S Priglinger; T Haslwanter
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

2.  Contralateral lateral rectus muscle recession in patients with Duane retraction syndrome type 3.

Authors:  M Snir; A Dotan; R Friling; Y Ron-Kella; N Goldenberg-Cohen; H Stiebel-Kalish
Journal:  Eye (Lond)       Date:  2013-12-06       Impact factor: 3.775

3.  Superior rectus transposition and medial rectus recession for Duane syndrome and sixth nerve palsy.

Authors:  Reshma A Mehendale; Linda R Dagi; Carolyn Wu; Danielle Ledoux; Suzanne Johnston; David G Hunter
Journal:  Arch Ophthalmol       Date:  2012-02

4.  Isolated y-splitting and recession of the lateral rectus muscle in patients with exo-duane syndrome.

Authors:  Federico G Velez; Guillermo Velez; Karen Hendler; Stacy L Pineles
Journal:  Strabismus       Date:  2012-09

5.  Y-Split Recession of the Medial Rectus Muscle as a Secondary and/or Unilateral Procedure in the Treatment of Esotropia with Distance/Near Disparity.

Authors:  Monika Wipf; Siegfried Priglinger; Anja Palmowski-Wolfe
Journal:  J Ophthalmol       Date:  2017-07-19       Impact factor: 1.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.